
Sovilnesib
CAS No. 2410796-79-9
Sovilnesib( AMG 650 )
Catalog No. M28250 CAS No. 2410796-79-9
Sovilnesib is a kinesin-like protein KIF18A inhibitor (WO2020132648). Sovilnesib can be used for the research of cancer.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 222 | Get Quote |
![]() ![]() |
10MG | 356 | Get Quote |
![]() ![]() |
25MG | 597 | Get Quote |
![]() ![]() |
50MG | 851 | Get Quote |
![]() ![]() |
100MG | 1152 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameSovilnesib
-
NoteResearch use only, not for human use.
-
Brief DescriptionSovilnesib is a kinesin-like protein KIF18A inhibitor (WO2020132648). Sovilnesib can be used for the research of cancer.
-
DescriptionSovilnesib is a kinesin-like protein KIF18A inhibitor (WO2020132648). Sovilnesib can be used for the research of cancer.(In Vitro):Sovilnesib is a kinesin-like protein KIF18A inhibitor.
-
In VitroCell Viability Assay Cell Line:Cancer cell lines Concentration:0-10 pM Incubation Time:96 and 144 hours Result:Inhibited tumor cell growth in a dose-dependent manner.
-
In VivoAnimal Model:Female nude mice without thymus with OVCAR-3 xenografts Dosage:10, 30, and 100 mg/kg Administration:Oral administration; daily, for 45 days Result:Had antitumor efficacy in a dose-dependent manner.
-
SynonymsAMG 650
-
PathwayCytoskeleton/Cell Adhesion Molecules
-
TargetMicrotubule/Tubulin
-
RecptorHistamine relase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2410796-79-9
-
Formula Weight564.65
-
Molecular FormulaC26H34F2N6O4S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (177.10 mM)
-
SMILESCc1cc(NC(c(ccc(NS(CCO)(=O)=O)c2)c2N2CCC3(CC3)CC2)=O)nc(N(CC2)CCC2(F)F)n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Watt GD, et al. Protective effect opf lodoxamide tromethamine on allergen inhalation challenge. J Allergy Clin Immunol. 1980 Oct;66(4):286-94.
molnova catalog



related products
-
VERU-111 analogue 13...
VERU-111 analogue 13f is a novel potent colchicine binding site inhibitor (CBSI) in tubulin with potential anticancer activities.
-
Verubulin hydrochlor...
Verubulin hydrochloride is an agent of blood brain barrier permeable microtubule-disrupting, with potent and broad-spectrum cytotoxic activities,with potent anticancer activity in human MX-1 breast and other mouse xenograft cancer models.
-
CKD-516
CKD-516 (Valecobulin, CKD516) is a potent beta-tubulin polymerization inhibitor with marked antitumor activity both in vitro and in vivo.